Shengmai injection combined with conventional therapy in treating Adriamycin-related cardiotoxicity: A protocol for systematic review and meta-analysis of randomized controlled trials

BACKGROUND: Tumor is a common and frequently-occurring disease that seriously threatens human health, and is one of the main causes of death. Adriamycin (ADM) is the most commonly used and effective anti-tumor chemotherapeutics in clinical practice, but they can cause severe cardiotoxicity, which ob...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Lanchun, Liu, Chao, Duan, Lian, Bai, Jing, Mao, Qiyuan, Jie, Wang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
3800
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7647611/
https://www.ncbi.nlm.nih.gov/pubmed/33157976
http://dx.doi.org/10.1097/MD.0000000000023084

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7647611/
https://www.ncbi.nlm.nih.gov/pubmed/33157976
http://dx.doi.org/10.1097/MD.0000000000023084

Ejemplares similares